Reverse-FOIA limitations on agency actions to disclose human gene therapy clinical trial data. Food and drug law journal [Food Drug Law J] Journal article

Title	Reverse-FOIA limitations on agency actions to disclose human gene therapy clinical trial data.
Author(s)	Diamond E
Institution	Kirkland & Ellis L.L.P., New York, NY, USA.
Source	Food Drug Law J 2008; 63(1):321-73.
MeSH	Advisory Committees Clinical Trials as Topic Disclosure Freedom Gene Therapy Genetic Privacy Government Agencies Government Regulation History, 20th Century Humans Information Management United States United States Food and Drug Administration
Language	eng
Pub Type(s)	Historical Article Journal Article
PubMed ID	18561463

Advertise on this site.